These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37094699)

  • 1. The sphingolipids ceramide and inositol phosphorylceramide protect the Leishmania major membrane from sterol-specific toxins.
    Haram CS; Moitra S; Keane R; Kuhlmann FM; Frankfater C; Hsu FF; Beverley SM; Zhang K; Keyel PA
    J Biol Chem; 2023 Jun; 299(6):104745. PubMed ID: 37094699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lathosterol Oxidase (Sterol C-5 Desaturase) Deletion Confers Resistance to Amphotericin B and Sensitivity to Acidic Stress in Leishmania major.
    Ning Y; Frankfater C; Hsu FF; Soares RP; Cardoso CA; Nogueira PM; Lander NM; Docampo R; Zhang K
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32611698
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    De Castro Levatti EV; Toledo MS; Watanabe Costa R; Bahia D; Mortara RA; Takahashi HK; Straus AH
    Front Microbiol; 2017; 8():1453. PubMed ID: 28824583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of sphingolipid synthase.
    Denny PW; Shams-Eldin H; Price HP; Smith DF; Schwarz RT
    J Biol Chem; 2006 Sep; 281(38):28200-9. PubMed ID: 16861742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A plate-based assay system for analyses and screening of the Leishmania major inositol phosphorylceramide synthase.
    Mina JG; Mosely JA; Ali HZ; Shams-Eldin H; Schwarz RT; Steel PG; Denny PW
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1553-61. PubMed ID: 20561598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins using Leishmania major.
    Haram CS; Moitra S; Keane R; Breslav E; Zhang K; Keyel PA
    J Vis Exp; 2022 Oct; (188):. PubMed ID: 36373947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine.
    Armitage EG; Alqaisi AQI; Godzien J; Peña I; Mbekeani AJ; Alonso-Herranz V; López-Gonzálvez Á; Martín J; Gabarro R; Denny PW; Barrett MP; Barbas C
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide.
    Xu X; Bittman R; Duportail G; Heissler D; Vilcheze C; London E
    J Biol Chem; 2001 Sep; 276(36):33540-6. PubMed ID: 11432870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies.
    Suzuki E; Tanaka AK; Toledo MS; Levery SB; Straus AH; Takahashi HK
    Biochim Biophys Acta; 2008 Mar; 1780(3):362-9. PubMed ID: 17976917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmentally regulated sphingolipid degradation in Leishmania major.
    Zhang O; Xu W; Balakrishna Pillai A; Zhang K
    PLoS One; 2012; 7(1):e31059. PubMed ID: 22299050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway.
    Feng M; Jin Y; Yang S; Joachim AM; Ning Y; Mori-Quiroz LM; Fromm J; Perera C; Zhang K; Werbovetz KA; Wang MZ
    Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():27-42. PubMed ID: 35994895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of perfringolysin O-lipid raft interaction.
    Nelson LD; Johnson AE; London E
    J Biol Chem; 2008 Feb; 283(8):4632-42. PubMed ID: 18089559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ketoconazole on lethal action of amphotericin B on Leishmania mexicana promastigotes.
    Ramos H; Saint-Pierre-Chazalet M; Bolard J; Cohen BE
    Antimicrob Agents Chemother; 1994 May; 38(5):1079-84. PubMed ID: 8067741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids.
    Goñi FM; Alonso A
    Biochim Biophys Acta; 2006 Dec; 1758(12):1902-21. PubMed ID: 17070498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol phosphorylceramide synthase null Leishmania are viable and virulent in animal infections where salvage of host sphingomyelin predominates.
    Kuhlmann FM; Key PN; Hickerson SM; Turk J; Hsu FF; Beverley SM
    J Biol Chem; 2022 Nov; 298(11):102522. PubMed ID: 36162499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets.
    Neumann A; Baginski M; Czub J
    J Am Chem Soc; 2010 Dec; 132(51):18266-72. PubMed ID: 21126070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmentally regulated sphingolipid synthesis in African trypanosomes.
    Sutterwala SS; Hsu FF; Sevova ES; Schwartz KJ; Zhang K; Key P; Turk J; Beverley SM; Bangs JD
    Mol Microbiol; 2008 Oct; 70(2):281-96. PubMed ID: 18699867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida.
    Denny PW; Field MC; Smith DF
    FEBS Lett; 2001 Feb; 491(1-2):148-53. PubMed ID: 11226438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of host sphingomyelin is essential for Leishmania virulence.
    Zhang O; Wilson MC; Xu W; Hsu FF; Turk J; Kuhlmann FM; Wang Y; Soong L; Key P; Beverley SM; Zhang K
    PLoS Pathog; 2009 Dec; 5(12):e1000692. PubMed ID: 20011126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the
    Mina JGM; Charlton RL; Alpizar-Sosa E; Escrivani DO; Brown C; Alqaisi A; Borsodi MPG; Figueiredo CP; de Lima EV; Dickie EA; Wei W; Coutinho-Silva R; Merritt A; Smith TK; Barrett MP; Rossi-Bergmann B; Denny PW; Steel PG
    ACS Infect Dis; 2021 Jan; 7(1):47-63. PubMed ID: 33291887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.